Stereoselective total synthesis of topographically constrained designer amino acids: 2′, 6′-dimethyl-β-methyltyrosines
Graphic
References (41)
Life Sciences
(1982)- et al.
Trends Neurosci.
(1985) Trends Pharm. Sci.
(1989)- et al.
Tetrahedron
(1993) - et al.
Tetrahedron Lett.
(1989) - et al.
Tetrahedron Lett.
(1989) - et al.
Tetrahedron
(1992) - et al.
Tetrahedron Lett.
(1992) - et al.
Tetrahedron
(1994) - et al.
Tetrahedron
(1991)
Tetrahedron Lett.
J. Magn. Reson.
Tetrahedron Lett.
Angew. Chem. Int. Ed. Engl.
J. Med. Chem.
J. Med. Chem.
Cited by (66)
Asymmetric total synthesis of (+)-dragmacidin D reveals unexpected stereocomplexity
2015, Organic LettersRational approach to the design of bioactive peptidomimetics: Recent developments in opioid agonist peptides
2015, Studies in Natural Products ChemistryCitation Excerpt :They are characterized by a “message” sequence (N-terminal tripeptide fragment) and an “address” domain (the C-terminal fragment) in which the Pro2 amino acid acts as stereochemical spacer between two pharmacophoric residues (Tyr1 and Trp3/Phe3) allowing EMs to exist as cis/trans isomers. The structural elements responsible for μ-selectivity are the second and third extracellular loops, intracellular carboxyl termini and extracellular amino termini of the MOR receptor, as established by site-directed mutagenesis studies [36]; furthermore Tyr1, Pro2, or d-Ala2 lipophilic residues in positions 3 or 4 and the amidation at the C-terminal, are important features for μ-selective agonists [37]. Many chemical strategies permit to improve specificity, biochemical stability, and permeability to BBB and most of them have been exhaustively reviewed (Fig. 2.7) [8,38–44].
An efficient total synthesis of (+)-heliannuol D
2010, Tetrahedron Asymmetry